Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ANRO compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
ANRO
Alto Neuroscience, Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
ANRO
Alto Neuroscience, Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Earnings history
Desk
News
Calendar
Saved
Search
Earnings history
last 4 reports each · paired by recency
Method
›
ANRO
1 of 4 reports
0 of 1
at or beyond implied
Report
implied
realized
× implied
Q2 FY26
±13.6%
▲
+10.69%
×0.79
LLY
3 of 4
at or beyond implied
Report
implied
realized
× implied
Q3 FY26
±5.1%
▲
+6.63%
×1.29
Q2 FY26
±6.2%
▲
+4.86%
×0.79
Q1 FY26
±5.3%
▲
+9.80%
×1.85
Feb 4 '26
±6.1%
▲
+10.33%
×1.69
= implied
ANRO realized, solid
LLY realized, hatched
One scale, both sides: full bar = 14%
× = |realized| ÷ implied
Source: market data
ANRO
Alto Neuroscience, Inc.
Change
22.40
▼
−4.56%
· post 22.40
Mkt cap
$886.9M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,412.87
▲
+2.85%
· post 1,417.05
Closed
Oct 30 '26
Mkt cap
$1.3T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
Closed
Oct 30 '26
ANRO
Alto Neuroscience, Inc.
vs
LLY
ELI Lilly & Co
22.40
▼
−4.56%
post 22.40
Price
1,412.87
▲
+2.85%
post 1,417.05
$886.9M
Mkt cap
$1.3T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
ANRO
22.40
▼
−4.56%
vs
LLY
1,412.87
▲
+2.85%
Closed
Oct 30 '26